Many people with lupus develop skin rash early on in the course of their illness. This is especially true in people from minority populations, such as African-Americans and Hispanics. Anti-malarial drugs such as hydroxycholoroquine are not just used for skin involvement, but are widely prescribed for lupus patients due to their ability to reduce inflammation and delay the absorption of damaging ultraviolet light by the skin. In this study, researchers hoped to learn what factors have an impact on how much time it takes for a lupus patient to develop skin damage.
Learn more
August 23, 2010
Hydroxycholoroquine May Protect Against Skin Involvement in Lupus
Labels:
lupus skin disease,
research enewsletter
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment